PROTALIX BIOTHERAPEUTICS INC - NOTE 4.500% 9/1

CUSIP: 74365AAB7

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Debt / NOTE 4.500% 9/1
Market price (% of par)
74.64%
Total 13F principal
$60,052,000
Principal change
-$9,000,000
Total reported market value
$45,367,000
Number of holders
11
Value change
-$6,904,000
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 74365AAB7?
CUSIP 74365AAB7 identifies 74365AAB7 - PROTALIX BIOTHERAPEUTICS INC - NOTE 4.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - NOTE 4.500% 9/1 as of Q1 2015

As of 31 Mar 2015, PROTALIX BIOTHERAPEUTICS INC - NOTE 4.500% 9/1 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $60,052,000 in principal (par value) of the bond. The largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, WOLVERINE ASSET MANAGEMENT LLC, FEDERATED INVESTORS INC /PA/, CITIGROUP INC, DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, Mohican Financial Management, LLC, ANGELO GORDON & CO., L.P., and Linden Advisors LP. This page lists 11 institutional bondholders reporting positions for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.